Ratings Balaji Amines Limited NSE India S.E.

Equities

BALAMINES

INE050E01027

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-07-12 am EDT			5-day change	1st Jan Change
2,361 ^INR	+1.50%		-0.71%	-11.53%

May. 10	Transcript : Balaji Amines Limited, Q4 2024 Earnings Call, May 10, 2024
May. 08	Balaji Amines' Consolidated Profit Jumps in Fiscal Q4; Shares Surge 10%	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

With a 2025 P/E ratio at 24.83 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
Over the past four months, analysts' average price target has been revised downwards significantly.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-11.53%	919M	-
ECOLAB INC.	+24.08%	70.28B	A-
SIKA AG	-3.00%	47.63B	A-
GIVAUDAN SA	+25.57%	45.14B	B+
FUJIFILM HOLDINGS CORPORATION	+34.90%	29.06B	A-
EMS-CHEMIE HOLDING AG	+7.71%	19.18B	C+
SYMRISE AG	+15.37%	17.52B	B+
CELANESE CORPORATION	-8.45%	15.54B	B+
POSCO FUTURE M CO., LTD.	-23.96%	15.38B	A-
NITTO DENKO CORPORATION	+26.68%	11.88B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes